KT-333 Phase 1 study ongoing with additional data expected in the second half of 2024 ...

Vividion Therapeutics, a subsidiary of Bayer, has commenced subject dosing in a Phase I clinical trial of its investigational oral signal transducer and activator of transcription 3 (STAT3 ...

Between the pandemic, social unrest and political turbulence, one senior says she both lost and gained something during her ...

ALCL patient tumors and models showed significant dysregulation of a protein called signal transducer and activator of transcription 3 (STAT3). STAT3 is a signaling protein that integrates ...

By Pooja Toshniwal Paharia In a recent study published in Scientific Reports , researchers investigated the mechanisms behind ...

These mice also showed stronger signs of an inflammatory signaling pathway called the IL-6/JAK/STAT3 pathway—the same one the team had implicated in liver metastasis in their 2019 study.

These mice also showed stronger signs of an inflammatory signaling pathway called the IL-6/JAK/STAT3 pathway—the same one the team had implicated in liver metastasis in their 2019 study.

UGT2B17, a metabolic enzyme known for regulating various endogenous molecules, has been identified to have heightened ...

It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad ...